These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 5096072)
41. [Prevention of transmission of infectious hepatitis by blood preparations through screening of GOT in blood donors]. Novák J; Urbánková J Cas Lek Cesk; 1969 Jun; 108(24):734-7. PubMed ID: 5783179 [No Abstract] [Full Text] [Related]
43. How FDA safeguards the blood supply. Stone BW FDA Consum; 1991 Jun; 25(5):12-5. PubMed ID: 10111728 [TBL] [Abstract][Full Text] [Related]
44. [Au-SH-antigen and hepatitis]. Dtsch Med Wochenschr; 1970 Aug; 95(32):1665. PubMed ID: 5433410 [No Abstract] [Full Text] [Related]
45. Parasitic infection from blood transfusions. Shulman IA MLO Med Lab Obs; 1992 Sep; 24(9):55-6, 58, 60. PubMed ID: 10121593 [No Abstract] [Full Text] [Related]
46. Posttransfusion hepatitis B infection after revised screening for hepatitis B. Arai M; Koshihara K; Takahashi Y; Fukutake K Int J Hematol; 1999 Jan; 69(1):61. PubMed ID: 10641447 [No Abstract] [Full Text] [Related]
47. Does prevalence of transfusion-transmissible viral infection reflect corresponding incidence in United States blood donors? Wang B; Schreiber GB; Glynn SA; Kleinman S; Wright DJ; Murphy EL; Busch MP; Transfusion; 2005 Jul; 45(7):1089-96. PubMed ID: 15987352 [TBL] [Abstract][Full Text] [Related]
49. Hepatitis B virus infection and transfusion medicine: science and the occult. Hollinger FB Transfusion; 2008 May; 48(5):1001-26. PubMed ID: 18454738 [No Abstract] [Full Text] [Related]
50. Incidence of hepatitis B virus (HBV) infection amongst clinically diagnosed acute viral hepatitis cases and relative risk of development of HBV infection in high risk groups in Calcutta. Hazra BR; Saha SK; Mazumder AK; Deb A; Sinha S Indian J Public Health; 1998; 42(2):56-8. PubMed ID: 10389512 [TBL] [Abstract][Full Text] [Related]
51. The continued risk of transfusion-transmitted AIDS. Kolins J Pathologist; 1986 Jun; 40(6):9-10. PubMed ID: 10277216 [No Abstract] [Full Text] [Related]
54. Donor screening for hepatitis B virus infection in a cell and tissue bank. Solves P; Mirabet V; Alvarez M; Vila E; Quiles F; Villalba JV; Montoro JA; Soler MA; Roig RJ Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905 [TBL] [Abstract][Full Text] [Related]
55. [The problem of post-transfusional viral hepatitis]. Del Prete S Haematol Lat; 1966; 9(2):137-43. PubMed ID: 5989699 [No Abstract] [Full Text] [Related]
56. [Statistical analysis of hepatitis due to blood transfusion at our hospital]. Ono M; Katayama T; Oshiro I; Shimura K Iryo; 1966 Feb; 20(2):136-42. PubMed ID: 5965160 [No Abstract] [Full Text] [Related]
57. [Liver dysfunction after blood transfusion. Comparison between deposited blood and paid blood]. Tamura M; Nakajima T Iryo; 1966 Nov; 20(11):1200-1. PubMed ID: 5982065 [No Abstract] [Full Text] [Related]
58. [The costs of blood and blood substitutes]. Gullbring B Lakartidningen; 1972 Dec; 69():Suppl 4:92-4. PubMed ID: 4656854 [No Abstract] [Full Text] [Related]
59. The use of blood and blood products. Dornette WH Clin Anesth; 1972; 8(2):249-84. PubMed ID: 5060919 [No Abstract] [Full Text] [Related]
60. Bad blood. Newman RJ; Podolsky D; Loeb P US News World Rep; 1994 Jun; 116(25):68-70, 72-8. PubMed ID: 10134824 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]